Physician profile
Shalini Katyal
NPI 1972713774
$1,389.96
in general payments reported to CMS, 2019-2025
8 companies · $67.00 in 2025
The $67.00 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2024: $1,219 · 2025: $67.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Consulting Fee: $200 · Travel and Lodging: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.60 |
| Consulting Fee | $200.00 |
| Travel and Lodging | $156.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $715.71 | 2024 | Neurostar Tms Therapy System |
| Janssen Scientific Affairs, LLC | $200.00 | 2024 | Spravato |
| Janssen Pharmaceuticals, INC | $171.26 | 2021-2024 | Spravato |
| Pharming Healthcare, INC. | $125.00 | 2024 | Ruconest |
| Abbvie INC. | $67.00 | 2025 | |
| Livanova USA, INC. | $45.86 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $38.46 | 2024 | Rejoyn |
| Axsome Therapeutics, INC. | $26.67 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shalini Katyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.